(HealthDay)—Smaller packages of Pfizer's coronavirus vaccine that could be available this fall might improve vaccine access and reduce the number of wasted doses, government documents show.
Sep 3, 2021
0
7
New research from the University of Virginia School of Medicine quantifies the antibody response generated by the Pfizer and Moderna COVID vaccines. The findings are some of the earliest to compare the two vaccines' antibody ...
Sep 2, 2021
0
290
A new laboratory study from Oregon Health & Science University finds that blood serum drawn from people previously vaccinated or naturally infected show "significantly reduced" defense against two widely circulating variants ...
Aug 26, 2021
0
404
Pfizer is seeking U.S. approval of a booster dose of its two-shot COVID-19 vaccine.
Aug 25, 2021
0
2
Britain on Monday announced it will take delivery of another 35 million doses of the Pfizer coronavirus vaccine in the second half of next year to "future-proof" its jabs rollout.
Aug 23, 2021
0
2
Pfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments.
Aug 23, 2021
0
2
The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations ...
Aug 23, 2021
1
808
Prime Minister Scott Morrison yesterday announced the Pfizer vaccine would become available to all Australians aged 16 to 39 from August 30.
Aug 20, 2021
0
2
Do I need a booster if I got the Johnson & Johnson vaccine?
Aug 20, 2021
0
116
The effectiveness of the Pfizer-BioNTech vaccine against COVID-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.
Aug 19, 2021
4
931
